Nationwide Recall: Stop Using Gas-X Extra Strength Softgels
Health officials are urging New Zealanders to cease using four specific lots of Gas-X Extra Strength Softgels 125 mg. following a nationwide recall announced by the U.S. Food and Drug Administration (FDA). The recall, initiated by pharmaceutical company Haleon, affects select batches of the over-the-counter gas-relief medication.
The FDA’s announcement detailed that the recall is due to concerns regarding manufacturing quality. While the specific nature of the quality issues hasn't been explicitly detailed in the provided information, the recall’s breadth suggests a potentially significant concern. Consumers are advised to discontinue use immediately and consult with a healthcare professional or pharmacist for guidance.
Haleon, the manufacturer of Gas-X, has not yet released a statement addressing the recall's impact on New Zealand specifically. However, given the medication's availability in pharmacies and retail outlets across the country, it’s highly likely that the affected lots are present in New Zealand. Consumers should carefully check the lot numbers printed on the packaging against those listed by the FDA (information not provided in original) to determine if their product is included in the recall.
Gas-X Extra Strength Softgels are commonly used to relieve gas and bloating. The medication's widespread popularity means this recall could impact a significant number of New Zealanders who rely on it for symptom relief. The FDA’s decision to issue a nationwide recall underscores the seriousness of the manufacturing concerns.
Further information regarding the recall, including specific lot numbers and instructions for consumers, is expected to be released by Haleon shortly. New Zealanders are advised to monitor the FDA website and local pharmacy notices for updates.
